News Release: Trump Administration Secures Historic Donation of Billions of Dollars in HIV Prevention Drugs | HIV.gov

News Release: Trump Administration Secures Historic Donation of Billions of Dollars in HIV Prevention Drugs | HIV.gov

Federal Response Blog Posts News Release: Trump Administration Secures Historic Donation of Billions of Dollars in HIV Prevention Drugs Yesterday, Health and Human Services Secretary Alex M. Azar II announced that Gilead Sciences, Inc. agreed to donate pre-exposure prophylaxis (PrEP) medication for up to 200,000 individuals each year for up to 11 years. LEARN MORE   Seeking your Input: Participate in Developing the First-ever STI Federal Action Plan Upcoming listening session and published Request for Information solicit stakeholder ideas for Federal STI Action Plan. LEARN MORE   HRSA’s Ryan White HIV/AIDS Program Observes Hepatitis Awareness Month, Advances Efforts to Eliminate HIV/HCV Coinfection HRSA’s HV/AIDS Bureau highlights the importance of testing and treating people coinfected with HIV and viral hepatitis and recognizes hepatitis C-related efforts underway throughout the Ryan White HIV/AIDS Program. LEARN MORE   Additional Evidence of the Effectiveness of HIV Treatment as Prevention Published in The Lancet New study results confirm that antiretroviral treatment that leads to sustained viral suppression prevents HIV transmission between gay male couples as well as it does among heterosexual couples. LEARN MORE

Digital Tools Blog Posts How to Write Successful Subject Lines HIV.gov is always exploring how to use data and analytics to make our communication efforts more effective. We recently did some work to identify components of successful subject lines. LEARN MORE

HIV/AIDS Basics Blog Posts What’s the Deal with Viral Hepatitis and HIV? Understanding how to prevent getting hepatitis B or C, who should get tested and how often, and what treatments are available is important for both people with HIV and people at risk for HIV. LEARN MORE